jag009
★★★

NJ,
2012-05-22 23:31
(4756 d 05:33 ago)

Posting: # 8607
Views: 3,087
 

 Adderall [Bioanalytics]

Post reply
Hi Everyone,

As per FDA, BE studies for Mixed Amphetamine (Adderall, Adderall XR) requires measurement of both D- and L-amphetamine in the plasma. What about the requirement of 5% difference in relative potency (total Assay) between test and reference product? Does one have to demonstrate that on both D and L forms of amphetamine?

Thanks

John
 
drgunasakaran1
★★  
avatar

2012-05-31 16:34
(4747 d 12:30 ago)

@ jag009
Posting: # 8644
Views: 2,357
 

 Adderall

Post reply
Dear Mr John,
The requirement of 5% difference in relative potency will be applicable for both D- and L-amphetamine.
—
Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn
 
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,684 registered users;
62 visitors (0 registered, 62 guests [including 14 identified bots]).
Forum time: 05:04 CEST (Europe/Vienna)

Nerds don’t just happen to dress informally.
They do it too consistently.
Consciously or not, they dress informally
as a prophylactic measure against stupidity.    Paul Graham

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5